Treatment parameters of the two study groups at the baseline and during follow-up period.</p
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Comparison of the clinicopathological parameters between the study groups.</p
Clinical parameters of the two study groups at the baseline and during follow-up.</p
Baseline parameters in the different groups prior to oral dabigatran treatment.</p
<p>Comparison of the main clinical parameters between baseline and during follow-up (or at final fol...
<p>Baseline and treatment (10-week) follow-up measures for the three study groups.</p
Change in outcome measures from baseline to post-intervention by treatment groups.</p
<p>Baseline Characteristics of the Study Population by Treatment Group [Quantitative Traits Are Show...
Baseline versus post-treatment characteristics in relation to clinical response.</p
<p>Baseline characteristics of the included studies: Treatment success group vs. AF recurrence group...
Demographic and clinical characteristics of the experimental and control groups at baseline.</p
Baseline characteristics for patients followed up in the control and intervention periods*.</p
<p>Baseline characteristics of the study population according to mortality at different follow-up ti...
<p>Baseline demographic and clinical values at randomisation according to study group.</p
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Comparison of the clinicopathological parameters between the study groups.</p
Clinical parameters of the two study groups at the baseline and during follow-up.</p
Baseline parameters in the different groups prior to oral dabigatran treatment.</p
<p>Comparison of the main clinical parameters between baseline and during follow-up (or at final fol...
<p>Baseline and treatment (10-week) follow-up measures for the three study groups.</p
Change in outcome measures from baseline to post-intervention by treatment groups.</p
<p>Baseline Characteristics of the Study Population by Treatment Group [Quantitative Traits Are Show...
Baseline versus post-treatment characteristics in relation to clinical response.</p
<p>Baseline characteristics of the included studies: Treatment success group vs. AF recurrence group...
Demographic and clinical characteristics of the experimental and control groups at baseline.</p
Baseline characteristics for patients followed up in the control and intervention periods*.</p
<p>Baseline characteristics of the study population according to mortality at different follow-up ti...
<p>Baseline demographic and clinical values at randomisation according to study group.</p
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Comparison of the clinicopathological parameters between the study groups.</p